The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Gastric bypass surgery vs intensive lifestyle and medical intervention for type 2 diabetes: the CROSSROADS randomised controlled trial
Open accessAbstract
Aims/hypothesisMounting evidence indicates that Roux-en-Y gastric bypass (RYGB) ameliorates type 2 diabetes, but randomised trials comparing surgical vs nonsurgical care are needed. With a parallel-group randomised controlled trial (RCT), we compared RYGB vs an intensive lifestyle and medical intervention (ILMI) for type 2 diabetes, including among patients with a BMI <35 kg/m2.MethodsBy use of a shared decision-making recruitment strategy targeting the entire at-risk population within an integrated community healthcare system, we screened 1,808 adults meeting inclusion criteria (age 25–64, with type 2 diabetes and a BMI 30–45 kg/m2). Of these, 43 were allocated via concealed, computer-generated random assignment in a 1:1 ratio to RYGB or ILMI. The latter involved ≥45 min of aerobic exercise 5 days per week, a dietitian-directed weight- and glucose-lowering diet, and optimal diabetes medical treatment for 1 year. Although treatment allocation could not be blinded, outcomes were determined by a blinded adjudicator. The primary outcome was diabetes remission at 1 year (HbA1c <6.0% [<42.1 mmol/mol], off all diabetes medicines).ResultsTwenty-three volunteers were assigned to RYGB and 20 to ILMI. Of these, 11 withdrew before receiving any intervention. Hence 15 in the RYGB group and 17 in the IMLI group were analysed throughout 1 year. The groups were equivalent regarding all baseline characteristics, except that the RYGB cohort had a longer diabetes duration (11.4 ± 4.8 vs 6.8 ± 5.2 years, p = 0.009). Weight loss at 1 year was 25.8 ± 14.5% vs 6.4 ± 5.8% after RYGB vs ILMI, respectively (p < 0.001). The ILMI exercise programme yielded a 22 ± 11% increase in V⋅O2max$$ \overset{\cdot }{V}{\mathrm{O}}_{2 \max } $$ (p<0.0001), whereas V⋅O2max$$ \overset{\cdot }{V}{\mathrm{O}}_{2 \max } $$ after RYGB was unchanged. Diabetes remission at 1 year was 60.0% with RYGB vs 5.9% with ILMI (p = 0.002). The HbA1c decline over 1 year was only modestly more after RYGB than ILMI: from 7.7 ± 1.0% (60.7 mmol/mol) to 6.4 ± 1.6% (46.4 mmol/mol) vs 7.3 ± 0.9% (56.3 mmol/mol) to 6.9 ± 1.3% (51.9 mmol/mol), respectively (p = 0.04); however, this drop occurred with significantly fewer or no diabetes medications after RYGB. No life-threatening complications occurred.Conclusions/interpretationCompared with the most rigorous ILMI yet tested against surgery in a randomised trial, RYGB yielded greater type 2 diabetes remission in mild-to-moderately obese patients recruited from a well-informed, population-based sample.Trial registration :ClinicalTrials.gov NCT01295229
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011 · cited 5×
“By use of a population-based recruitment strategy to enrol patients with type 2 diabetes and a BMI of 30–45 kg/m(2), we conducted a prospective RCT comparing RYGB to an intensive lifestyle and medical intervention (ILMI), including aggressive, supervised dieting and exercise, modelled after the Diabetes Prevention Pro…”
InfluentialMurray, C. J. L., Vos, T., Lozano, R., Naghavi, M., Flaxman, A. D., Michaud, C., Ezzati, M., Shibuya, K., Salomon, J. A., Abdalla, S., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61689-4 · Cited by 8,888
Effects of Bariatric Surgery on Mortality in Swedish Obese Subjects
Sjöström, L., Narbro, K., Sjöström, C. D., Karason, K., Larsson, B., Wedel, H., Lystig, T., Sullivan, M., Bouchard, C., Carlsson, B., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa066254 · Cited by 4,668 · cited 1×
“Large observational studies report that in severely obese individuals, bariatric surgery is associated with long-term reductions in all major cardiovascular disease (CVD) risk factors [5, 6], CVD events such as myocardial infarctions and strokes [7], cancer [8] and all-cause mortality [9, 10], including a 92% decrease…”
Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery
Sjöström, L., Lindroos, A.-K., Peltonen, M., Torgerson, J., Bouchard, C., Carlsson, B., Dahlgren, S., Larsson, B., Narbro, K., Sjöström, C. D., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa035622 · Cited by 4,457
Inzucchi, S. E., Bergenstal, R. M., Buse, J. B., Diamant, M., Ferrannini, E., Nauck, M., Peters, A. L., Tsapas, A., Wender, R., & Matthews, D. R. (2012) · Diabetologia · doi:10.1007/s00125-012-2534-0 · Cited by 3,919
Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach
Inzucchi, S. E., Bergenstal, R. M., Buse, J. B., Diamant, M., Ferrannini, E., Nauck, M., Peters, A. L., Tsapas, A., Wender, R., & Matthews, D. R. (2012) · Diabetes Care · doi:10.2337/dc12-0413 · Cited by 3,207
Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes
The Look AHEAD Research Group (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1212914 · Cited by 2,908
Long-term mortality after gastric bypass surgery
Adams, T. D., Gress, R. E., Smith, S. C., Halverson, R. C., Simper, S. C., Rosamond, W. D., LaMonte, M. J., Stroup, A. M., & Hunt, S. C. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa066603 · Cited by 2,572 · cited 1×
“Large observational studies report that in severely obese individuals, bariatric surgery is associated with long-term reductions in all major cardiovascular disease (CVD) risk factors [5, 6], CVD events such as myocardial infarctions and strokes [7], cancer [8] and all-cause mortality [9, 10], including a 92% decrease…”
Weight and Type 2 Diabetes after Bariatric Surgery: Systematic Review and Meta-analysis
Buchwald, H., Estok, R., Fahrbach, K., Banel, D., Jensen, M. D., Pories, W. J., Bantle, J. P., & Sledge, I. (2009) · The American Journal of Medicine · doi:10.1016/j.amjmed.2008.09.041 · Cited by 2,551 · cited 2×
“Duality of interest DA receives research funding, has received salary support and received free access to the SDM aids used in this study, as a medical editor for the not-for-profit (501[3]c) Informed Medical 952 Diabetologia (2016) 59:945–953”
Bariatric Surgery versus Intensive Medical Therapy in Obese Patients with Diabetes
Schauer, P. R., Kashyap, S. R., Wolski, K., Brethauer, S. A., Kirwan, J. P., Pothier, C. E., Thomas, S., Abood, B., Nissen, S. E., & Bhatt, D. L. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1200225 · Cited by 2,164
Gastrointestinal Surgery for Severe Obesity
Panel, C. D. C. (1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-115-12-956 · Cited by 2,163
Bariatric Surgery versus Intensive Medical Therapy for Diabetes — 3-Year Outcomes
Schauer, P. R., Bhatt, D. L., Kirwan, J. P., Wolski, K., Brethauer, S. A., Navaneethan, S. D., Aminian, A., Pothier, C. E., Kim, E. S. H., Nissen, S. E., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1401329 · Cited by 1,901
Bariatric Surgery versus Conventional Medical Therapy for Type 2 Diabetes
Mingrone, G., Panunzi, S., De Gaetano, A., Guidone, C., Iaconelli, A., Leccesi, L., Nanni, G., Pomp, A., Castagneto, M., Ghirlanda, G., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1200111 · Cited by 1,791
Bariatric Surgery and Long-term Cardiovascular Events
Sjöström, L., Peltonen, M., Jacobson, P., Sjöström, C. D., Karason, K., Wedel, H., Ahlin, S., Anveden, Å., Bengtsson, C., Bergmark, G., et al. (2012) · JAMA · doi:10.1001/jama.2011.1914 · Cited by 1,656
Dixon, J. B., O’Brien, P. E., Playfair, J., Chapman, L., Schachter, L. M., Skinner, S., Proietto, J., Bailey, M., & Anderson, M. (2008) · JAMA · doi:10.1001/jama.299.3.316 · Cited by 1,434
Perioperative safety in the longitudinal assessment of bariatric surgery
(2009) · New England Journal of Medicine · doi:10.1056/nejmoa0901836 · Cited by 1,392 · cited 1×
“3% [30–32], similar to that for cholecystectomy and hysterectomy.”
Gloy, V. L., Briel, M., Bhatt, D. L., Kashyap, S. R., Schauer, P. R., Mingrone, G., Bucher, H. C., & Nordmann, A. J. (2013) · BMJ · doi:10.1136/bmj.f5934 · Cited by 1,351
How do we define cure of diabetes?
Buse, J. B., Caprio, S., Cefalu, W. T., Ceriello, A., Del Prato, S., Inzucchi, S. E., McLaughlin, S., Phillips, G. L., Robertson, R. P., Rubino, F., et al. (2009) · Diabetes Care · doi:10.2337/dc09-9036 · Cited by 1,003
Bariatric surgery and prevention of type 2 diabetes in Swedish obese subjects
Carlsson, L. M. S., Peltonen, M., Ahlin, S., Anveden, Å., Bouchard, C., Carlsson, B., Jacobson, P., Lönroth, H., Maglio, C., Näslund, I., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1112082 · Cited by 794
Sjöström, L., Gummesson, A., Sjöström, C. D., Narbro, K., Peltonen, M., Wedel, H., Bengtsson, C., Bouchard, C., Carlsson, B., Dahlgren, S., et al. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70159-7 · Cited by 770
Ikramuddin, S., Korner, J., Lee, W.-J., Connett, J. E., Inabnet, W. B., Billington, C. J., Thomas, A. J., Leslie, D. B., Chong, K., Jeffery, R. W., et al. (2013) · JAMA · doi:10.1001/jama.2013.5835 · Cited by 735
Trends in mortality in bariatric surgery: a systematic review and meta-analysis
Buchwald, H., Estok, R., Fahrbach, K., Banel, D., & Sledge, I. (2007) · Surgery · doi:10.1016/j.surg.2007.07.018 · Cited by 685
NIH conference. Gastrointestinal surgery for severe obesity. Consensus Development Conference Panel.
(1991) · PubMed · Cited by 496
Hormonal and Metabolic Mechanisms of Diabetes Remission after Gastrointestinal Surgery
Thaler, J. P., & Cummings, D. E. (2009) · Endocrinology · doi:10.1210/en.2009-0367 · Cited by 443
Self-citationBariatric Surgery Versus Intensive Medical Therapy in Obese Patients With Diabetes
Schauer, P. R., Kashyap, S. R., Wolski, K., Brethauer, S. A., Kirwan, J. P., Pothier, C. E., Thomas, S., Abood, B., Nissen, S. E., & Bhatt, D. L. (2013) · Survey of Anesthesiology · doi:10.1097/sa.0b013e31827f316e · Cited by 410
Long-term Outcomes of Bariatric Surgery: A National Institutes of Health Symposium
Courcoulas, A. P., Yanovski, S. Z., Bonds, D., Eggerman, T. L., Horlick, M., Staten, M. A., & Arterburn, D. E. (2014) · JAMA Surgery · doi:10.1001/jamasurg.2014.2440 · Cited by 325
Self-citationBariatric Surgery Versus Conventional Medical Therapy for Type 2 Diabetes
Mingrone, G., Panunzi, S., De Gaetano, A., Guidone, C., Iaconelli, A., Leccesi, L., Nanni, G., Pomp, A., Castagneto, M., Ghirlanda, G., et al. (2013) · Survey of Anesthesiology · doi:10.1097/01.sa.0000425546.30282.26 · Cited by 277
Halperin, F., Ding, S.-A., Simonson, D. C., Panosian, J., Goebel-Fabbri, A., Wewalka, M., Hamdy, O., Abrahamson, M., Clancy, K., Foster, K., et al. (2014) · JAMA Surgery · doi:10.1001/jamasurg.2014.514 · Cited by 245
Surgical vs Medical Treatments for Type 2 Diabetes Mellitus: A Randomized Clinical Trial
Courcoulas, A. P., Goodpaster, B. H., Eagleton, J. K., Belle, S. H., Kalarchian, M. A., Lang, W., Toledo, F. G. S., & Jakicic, J. M. (2014) · JAMA Surgery · doi:10.1001/jamasurg.2014.467 · Cited by 225
Pournaras, D. J., Aasheim, E. T., Søvik, T. T., Andrews, R., Mahon, D., Welbourn, R., Olbers, T., & le Roux, C. W. (2012) · Journal of British Surgery · doi:10.1002/bjs.7704 · Cited by 181
Recent Improvements in Bariatric Surgery Outcomes
Encinosa, W. E., Bernard, D., Du, D., & Steiner, C. (2009) · Medical Care · doi:10.1097/mlr.0b013e31819434c6 · Cited by 155
DeMaria, E. J., Winegar, D. A., Pate, V. W., Hutcher, N. E., Ponce, J., & Pories, W. J. (2010) · Annals of Surgery · doi:10.1097/sla.0b013e3181f2aed0 · Cited by 137 · cited 1×
“3% [30–32], similar to that for cholecystectomy and hysterectomy.”
Kolotkin, R. L., Crosby, R. D., Pendleton, R. C., Strong, M. B., Gress, R. E., & Adams, T. D. (2003) · Obesity Surgery · doi:10.1381/096089203765887688 · Cited by 111
van Nunen, A. M. A., Wouters, E., Vingerhoets, A. J. J. M., Hox, J. J., & Geenen, R. (2007) · Obesity Surgery · doi:10.1007/s11695-007-9241-9 · Cited by 95
Randomized Trial of a Video‐Based Patient Decision Aid for Bariatric Surgery
Arterburn, D. E., Westbrook, E. O., Bogart, T. A., Sepucha, K., Bock, S. N., & Weppner, W. G. (2011) · Obesity · doi:10.1038/oby.2011.65 · Cited by 87
Self-citationWong, K., Glovaci, D., Malik, S., Franklin, S. S., Wygant, G. D., Iloeje, U. H., Kan, H., & Wong, N. D. (2012) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2012.03.006 · Cited by 64
Arterburn, D. E., Flum, D. R., Westbrook, E. O., Fuller, S., Shea, M. A., Bock, S. N., Landers, J. T., Kowalski, K., Turnbull, E., & Cummings, D. E. (2013) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2013.05.006 · Cited by 29
Self-citationSurgical vs Lifestyle Treatment for Type 2 Diabetes
Ludwig, D. S., Ebbeling, C. B., & Livingston, E. H. (2012) · JAMA · doi:10.1001/2012.jama.10156 · Cited by 11
Cited by
Bariatric Surgery versus Intensive Medical Therapy for Diabetes — 5-Year Outcomes
Schauer, P. R., Bhatt, D. L., Kirwan, J. P., Wolski, K., Aminian, A., Brethauer, S. A., Navaneethan, S. D., Singh, R. P., Pothier, C. E., Nissen, S. E., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1600869 · Cited by 2,934
Benefits and Risks of Bariatric Surgery in Adults: A Review
Arterburn, D. E., Telem, D. A., Kushner, R. F., & Courcoulas, A. P. (2020) · JAMA · doi:10.1001/jama.2020.12567 · Cited by 1,251
Self-citationRubino, F., Nathan, D. M., Eckel, R. H., Schauer, P. R., Alberti, K. G. M. M., Zimmet, P. Z., Del Prato, S., Ji, L., Sadikot, S. M., Herman, W. H., et al. (2016) · Diabetes Care · doi:10.2337/dc16-0236 · Cited by 1,008
Self-citationMechanick, J. I., Apovian, C., Brethauer, S., Garvey, W. T., Joffe, A. M., Kim, J., Kushner, R. F., Lindquist, R., Pessah-Pollack, R., Seger, J., et al. (2020) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2019.10.025 · Cited by 608
Mechanick, J. I., Apovian, C., Brethauer, S., Garvey, W. T., Joffe, A. M., Kim, J., Kushner, R. F., Lindquist, R., Pessah-Pollack, R., Seger, J., et al. (2019) · Endocrine Practice · doi:10.4158/gl-2019-0406 · Cited by 510
Metadata
- Authors
- Cummings, D. E., Arterburn, D. E., Westbrook, E. O., Kuzma, J. N., Stewart, S. D., Chan, C. P., Bock, S. N., Landers, J. T., Kratz, M., Foster-Schubert, K. E., & Flum, D. R.
- Venue
- Diabetologia
- Published
- 2016-03-17
- Volume
- 59
- Issue
- 5
- Pages
- 945-953
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- OpenAlex
- W2308455762
- Cited by
- 314
- References
- 38
- FWCI
- 36.51
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.